SCHEMBL5835012

SCHEMBL5835012

COc1ccc(-c2nc3cc(-c4ccc5c(c4)OOC5)ccc3o2)cc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.48
▸ NPC1 O15118 7/20 0.45
▸ RAB9A P51151 7/20 0.43
▸ HPSE Q9Y251 3/20 0.41
▸ PTGS2 P35354 7/20 0.40
▸ GFER P55789 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ TP53 P04637 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ NFKB1 P19838 2/20 0.39
▸ NFKB2 Q00653 2/20 0.39
▸ RELA Q04206 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ HSPD1 P10809 1/20 0.38
▸ PTPN2 P17706 1/20 0.38
▸ PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5834626 0.86 RAB9A (0.43) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834886 0.83 NPC1 (0.54) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834515 0.82 ALOX5 (0.70) ALOX5NPC1RAB9APTGS2GFER
SCHEMBL5835014 0.82 HPSE (0.56) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834595 0.80 ALOX5 (0.67) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834409 0.80 ALOX5 (0.56) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834493 0.80 NPC1 (0.59) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834359 0.79 ALOX5 (0.55) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834837 0.79 ALOX5 (0.55) ALOX5NPC1RAB9AHPSEPTGS2
SCHEMBL5834164 0.78 HPSE (0.55) ALOX5NPC1RAB9AHPSEPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138425-B2 Phthalimide carboxylic acid derivatives OXFORD GLYCOSCIENCE (UK) LTD. (GB) 2006-11-21 — — US disclosed
US-20050203153-A1 Phthalimide carboxylic acid derivatives OXFORD GLYCOSCIENCE (UK) LTD. (GB) 2005-09-15 — — US disclosed
EP-1483261-A1 PHTHALIMIDE CARBOXYLIC ACID DERIVATIVES Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) 2004-12-08 — — EP disclosed
WO-2003074516-A1 PHTHALIMIDE CARBOXYLIC ACID DERIVATIVES OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203153-A1 Phthalimide carboxylic acid derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, IDH1 ALOX5 1038/4885NPC1 2102/4885RAB9A 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback